(S (NP (JJ Deep) (NN generative) (NNS models)) (VP (VBP are) (VP (VBG attracting) (NP (JJ great) (NN attention)) (PP (IN as) (NP (NP (DT a) (JJ new) (JJ promising) (NN approach)) (PP (IN for) (NP (JJ molecular) (NN design))))))) (. .))
(S (NP (DT All) (NNS models)) (VP (VBD reported) (ADVP (RB so) (RB far) (S (VP (VBP are) (VP (VBN based) (PP (IN on) (NP (CC either) (NP (JJ variational) (NN autoencoder) (-LRB- -LRB-) (NN VAE) (-RRB- -RRB-)) (CC or) (NP (JJ generative) (JJ adversarial) (NN network)))) (PRN (-LRB- -LRB-) (NP (NN GAN)) (-RRB- -RRB-))))))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP propose) (NP (DT a) (JJ new) (NN type) (NN model)) (PP (VBN based) (PP (IN on) (NP (DT an) (NML (S (VP (ADVP (RB adversarially)) (VBN regularized)))) (NN autoencoder)))) (PRN (-LRB- -LRB-) (NP (NN ARAE)) (-RRB- -RRB-))) (. .))
(S (S (NP (PRP It)) (ADVP (RB basically)) (VP (VBZ uses) (NP (NN latent) (NNS variables)) (PP (IN like) (NP (NNP VAE))))) (, ,) (CC but) (S (NP (NP (DT the) (NN distribution)) (PP (IN of) (NP (DT the) (NN latent) (NNS variables)))) (VP (VBZ is) (VP (VBN obtained) (PP (IN by) (NP (JJ adversarial) (NN training))) (PP (IN like) (PP (IN in) (NP (NNP GAN))))))) (. .))
(S (NP (DT The) (JJ latter)) (VP (VBZ is) (VP (VBN intended) (S (VP (TO to) (VP (VB avoid) (NP (NP (DT both) (JJ inappropriate) (NN approximation)) (PP (IN of) (NP (NP (JJ posterior) (NN distribution)) (PP (IN in) (NP (NP (NNP VAE)) (CC and) (NP (NN difficulty))))))) (PP (IN in) (S (VP (VBG handling) (NP (JJ discrete) (NNS variables)) (PP (IN in) (NP (NNP GAN))))))))))) (. .))
(S (NP (PRP$ Our) (NN benchmark) (NN study)) (VP (VBD showed) (SBAR (IN that) (S (NP (NNP ARAE)) (ADVP (RB indeed)) (VP (VBD outperformed) (NP (JJ conventional) (NNS models)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NN validity) (, ,) (NN uniqueness) (, ,) (CC and) (NN novelty)) (PP (IN per) (NP (ADJP (VBN generated)) (NN molecule))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD demonstrated) (NP (NP (JJ successful) (JJ conditional) (NN generation)) (PP (IN of) (NP (ADJP (NN drug) (HYPH -) (JJ like)) (NNS molecules)))) (PP (IN with) (NP (NN ARAE))) (PP (IN for) (NP (NP (DT both) (NNS cases)) (PP (IN of) (NP (ADJP (JJ single) (CC and) (JJ multiple)) (NNS properties) (NN control)))))) (. .))
(S (PP (IN As) (NP (DT a) (JJ potential) (NML (JJ real) (HYPH -) (NN world)) (NN application))) (, ,) (NP (PRP we)) (VP (MD could) (VP (VB generate) (NP (NNP EGFR) (NNS inhibitors)) (S (VP (VBG sharing) (NP (NP (DT the) (NNS scaffolds)) (PP (IN of) (NP (VBN known) (JJ active) (NNS molecules)))) (PP (IN while) (S (VP (VBG satisfying) (NP (ADJP (NN drug) (HYPH -) (JJ like)) (NNS conditions)) (ADVP (RB simultaneously))))))))) (. .))
